Is berberine as good as metformin?

For blood sugar, no. Metformin's subrating is 9.0 against berberine's 8.2, and metformin has outcome trials while berberine has meta-analyses of small marker studies. Berberine does beat it on fatty liver, 7.5 against 5.5, and it does not blunt training adaptation. No trial has ever randomized people to one against the other, so any strict equivalence claim is unsupported.

Can I take metformin and berberine together?

There is no good reason to. Both partially inhibit mitochondrial Complex I and activate AMPK, so the mechanisms are redundant rather than additive. What stacks reliably is the gut burden, since loose stools and cramping are the main side effect of each. If your current one is not working after a full 12 weeks, switch instead of adding.

Which is cheaper, metformin or berberine?

Metformin, usually. Generic immediate-release runs $4 to $15 a month through pharmacy discount programs and extended-release runs $15 to $30. Berberine HCl at the studied 1.5 g a day runs $15 to $25, and dihydroberberine runs $40 to $60. Both figures were extracted from the source reports and priced 2026-09-07.

How long before I know whether it is working?

Twelve weeks on either one. Berberine moves post-meal glucose within about seven days and metformin moves fasting glucose within about a week, but the assessment window on both reports is 12 weeks and full effect lands at 12 weeks. Book the follow-up labs at the start so the decision gets made on numbers.

Does berberine interact with my medications?

Quite possibly. Guo 2012 showed repeated berberine dosing inhibits CYP2D6, CYP2C9 and CYP3A4 in humans, which covers statins, warfarin and DOACs, cyclosporine, tacrolimus, macrolides and many antidepressants. Being sold without a prescription says nothing about interaction risk. Take your full medication list to a pharmacist before the first capsule, especially with transplant drugs or anticoagulants.

Is metformin a longevity drug?

Not yet, on the evidence. Barzilai 2016 makes the case for testing it, and TAME was designed to run that test, but no randomized healthy-adult longevity result has read out. Bannister 2014 is observational and confounded by treatment selection. Its own report calls healthy-adult longevity use speculative.

Who should avoid each one?

Metformin is contraindicated below eGFR 30 and in acute kidney injury, sepsis, severe dehydration, severe liver disease, active alcohol abuse, decompensated heart failure and hypoxic states, and needs a hold around iodinated contrast. Berberine is out in pregnancy, breastfeeding, neonates and jaundiced infants, while trying to conceive without guidance, and alongside warfarin, DOACs, statins, cyclosporine, tacrolimus or CYP-sensitive polypharmacy.

Head-to-Head Comparison

Metformin vs Berberine: Which Is Better for Blood Sugar?

Should I take metformin or berberine?

Reviewed 09/07/2026

Metformin scores 6.9 and berberine 6.8, so the gap is meaningless. Metformin owns blood sugar with decades of outcome trials behind it. Berberine owns fatty liver, needs no prescription, and stays out of the way of your training. Generic metformin also costs less than the supplement.

Metformin 6.9, berberine 6.8. Pick by what you want fixed, not by the scores.
Both work through the same trick: partial Complex I inhibition that switches on AMPK. Running both is redundant, not synergistic.
Metformin has hard outcome data (UKPDS 34, DPP). Berberine has meta-analyses of small trials, most of them regional and short.
Generic metformin runs $4 to $30 a month. Berberine runs $15 to $25. The prescription drug is the cheap one.
Berberine wins the liver row on subratings (7.5 against 5.5) and it wins on training, because metformin blunts aerobic and hypertrophy gains in older adults.
Berberine inhibits CYP2D6, CYP2C9 and CYP3A4, so it collides with statins, warfarin and many antidepressants. It looks safer than it is.

At a Glance

Option A

Metformin

6.9 / 10 Worth trying

Upside

Efficacy 4.3
Breadth 4.0
Evidence 4.8
Speed 3.0
Durability 2.0
Bioindividuality 3.2

Downside

Safety Risk 2.0
Side Effects 2.7
Cost 1.2
Effort 1.2
Opportunity Cost 2.0
Dependency 3.0
Reversibility 1.2

Best at:

Blood Sugar 9.0
Metabolic Health 8.5
Cardiovascular 7.2
Hormonal 7.0

Prescription biguanide. BioHarmony 6.9, worth trying.

Read full BioHarmony report →

Option B

Berberine

6.8 / 10 Worth trying

Upside

Efficacy 3.8
Breadth 3.9
Evidence 3.9
Speed 3.0
Durability 2.0
Bioindividuality 3.0

Downside

Safety Risk 2.0
Side Effects 3.0
Cost 1.4
Effort 2.0
Opportunity Cost 1.5
Dependency 1.0
Reversibility 1.2

Best at:

Blood Sugar 8.2
Metabolic Health 8.0
Hormonal 7.6
Liver Detox 7.5

Over-the-counter plant alkaloid. BioHarmony 6.8, worth trying.

Read full BioHarmony report →

Head-to-Head Verdict

Use Case	Winner	Rationale
Blood Sugar	Metformin	Metformin subrating 9.0 against berberine's 8.2, and the evidence tiers are not close. UKPDS 34 randomized 753 overweight adults with new type 2 diabetes and cut diabetes-related endpoints, diabetes-related death and all-cause mortality. Berberine's glucose case rests on Lan 2015 and Yin 2008, both pooling small trials.
Metabolic Health	Tie	Metformin 8.5 against berberine 8.0, and both are defensible. Liu 2025 pooled 12 randomized placebo-controlled trials in 889 people and found berberine lowered triglycerides, fasting glucose, waist circumference, LDL-C, total cholesterol and 2-hour glucose. That is the full metabolic syndrome cluster, which metformin does not touch as broadly.
Liver Detox	Berberine	Berberine 7.5 against metformin 5.5, the widest gap that favors the supplement. Nie 2024 pooled 10 randomized trials in 811 people with fatty liver and found improvements in liver enzymes, lipids, insulin resistance and steatosis markers. Yan 2015 ran 500 mg three times daily for 16 weeks in 184 patients. Metformin has no equivalent liver readout.
Cardiovascular	Metformin	Metformin 7.2 against berberine 6.8, and the reason is event data rather than lipid panels. UKPDS 34 reduced myocardial infarction, and Holman 2008 showed the metformin subgroup kept lower MI and all-cause mortality ten years after the trial ended. Berberine has Koppen 2017 and Blais 2023 on lipid numbers, which are markers, not events.
Hormonal	Tie	Berberine leads on the subrating, 7.6 against 7.0, and the trial evidence points the other way. Lord 2003 pooled 13 randomized trials in 543 women with PCOS and improved ovulation odds against placebo. Berberine's PCOS protocol runs 12 weeks with no pooled ovulation endpoint behind it. Score says berberine, evidence says metformin, so call it even.
Fertility Female	Metformin	Metformin 6.8 against berberine 6.0, and the safety line settles it. Berberine is contraindicated in pregnancy, in breastfeeding and while trying to conceive without clinician guidance, because Chan 1993 showed it displaces bilirubin from albumin. If conception is the goal, one of these two has to stop before you get there.
Gut Health	Berberine	Metformin holds the higher subrating, 6.0 against 5.4, and berberine still wins this row on specifics. Chen 2023 tested a berberine-containing triple therapy in 300 people with H. pylori against quadruple therapy comparators. Li 2024 pooled 10 trials in 952 people with ulcerative colitis where berberine added to 5-ASA improved endoscopic and inflammatory markers.
Strength Power	Berberine	Metformin holds the higher subrating, 3.5 against 2.0, and it is the wrong answer for anyone who lifts. Walton 2019 ran a 14-week resistance-training trial in older adults and found metformin blunted the hypertrophy response. Konopka 2019 found the same for aerobic and mitochondrial adaptations over 12 weeks. Berberine carries no such signal.
Body Composition	Tie	Berberine 5.8 against metformin 5.5, which is noise. Elahi Vahed 2026 pooled 23 trials and found modest reductions in body weight, BMI and waist circumference, with no effect on waist-hip ratio. Neither of these is a weight-loss drug, and choosing between them on that basis is choosing between two small numbers.

Cost Comparison

Intervention	Monthly Cost	Notes
Metformin	$4 to $30	Extracted from the source report, priced 2026-09-07, retail pharmacy channel. Generic immediate-release runs $4 to $15 a month through pharmacy discount programs and generic extended-release runs $15 to $30, at the standard titration toward 1000 mg twice daily. Off-label longevity telehealth sells the same molecule at a large markup.
Berberine	$15 to $25	Extracted from the source report, priced 2026-09-07, retail channel. That is standard berberine HCl at 1.5 g a day, which is the 500 mg three times daily protocol the trials used. Dihydroberberine runs $40 to $60 a month. Product quality and label accuracy cost you more than the sticker price does, because botanical sourcing varies far more than price.
The difference	The prescription drug is cheaper, by up to $20 a month	Generic immediate-release metformin at $4 to $15 undercuts berberine at $15 to $25. The supplement you can buy today costs more than the drug you need an appointment for.Money is a weak tie-breaker here either way, because both sit under $30 a month. Spend the decision on evidence, on your training, and on whether you can get a prescriber to write it.

When to Switch

Both move post-meal glucose inside a week, so the first fortnight tells you nothing worth acting on. The assessment window is 12 weeks on each side, and full effect lands at 12 weeks on each side, so judge either one on a 12-week lab panel and not on how you feel.

Move from berberine to metformin when a full 12-week course at 500 mg three times daily leaves fasting glucose or HbA1c where it started, when you are heading toward conception, or when you need a drug your cardiologist will recognise. Move from metformin to berberine when the GI burden survives the slow titration, when your training results have stalled and Walton 2019 or Konopka 2019 look like your situation, when fatty liver is the actual target, or when you cannot get a prescriber to write it.

Do not run both. They inhibit the same mitochondrial Complex I and activate the same AMPK, so the second one buys extra loose stools rather than extra effect. Whichever direction you go, stop one before starting the other, start the new one at its lowest step, and get a berberine interaction check against your statin, anticoagulant or antidepressant before the first capsule.

Who Should Pick What?

Adult with diagnosed type 2 diabetes

Metformin

Blood-sugar subrating 9.0 and the only outcome trials in this comparison. UKPDS 34 cut diabetes-related death and all-cause mortality in overweight patients, and Holman 2008 showed the effect persisted a decade later. Nothing on the berberine side reaches that tier.

Prediabetic who lifts weights three or more times a week

Berberine

Metformin blunts what you are training for. Walton 2019 found blunted hypertrophy over 14 weeks and Konopka 2019 found attenuated aerobic and mitochondrial adaptation over 12 weeks, both in older adults. Berberine carries no equivalent signal and still moves fasting glucose.

Fatty liver with raised ALT alongside insulin resistance

Berberine

Liver subrating 7.5 against 5.5. Nie 2024 pooled 10 trials in 811 patients showing better liver enzymes, lipids and steatosis markers, and Yan 2015 ran the 16-week protocol in 184 patients. Keep it as an adjunct to diet change rather than a replacement for it.

Woman with insulin-resistant PCOS who wants to conceive this year

Metformin

Lord 2003 pooled 13 trials in 543 women and improved ovulation odds. Berberine is contraindicated while trying to conceive without clinician guidance, and Chan 1993 is why. Conception timing removes the choice before efficacy does.

On a statin, a DOAC, or a CYP2D6-metabolized antidepressant

Metformin

Guo 2012 showed repeated berberine dosing inhibits CYP2D6, CYP2C9 and CYP3A4 in humans. That is a real interaction surface against statins, warfarin, DOACs, cyclosporine, tacrolimus, macrolides and many antidepressants. Metformin's interaction list is shorter and better mapped.

eGFR under 30, or a history of lactic acidosis risk

Berberine

Metformin is contraindicated below eGFR 30 and should not be started between 30 and 45, because metformin-associated lactic acidosis concentrates in renal impairment, hypoxia, sepsis and severe liver disease. Berberine has its own kidney subrating of 2.0, so clear either one with your clinician first.

Metabolically healthy, chasing longevity, normal labs

Tie

Neither. Metformin's healthy-adult longevity case is unproven, TAME has not read out, and it may cost you training adaptations in the meantime. Berberine's own report calls it a targeted metabolic tool rather than a foundational supplement, and says healthy users usually see little.

Pregnant, breastfeeding, or planning conception in the next months

Tie

Neither without a clinician driving. Berberine is contraindicated in pregnancy, breastfeeding and neonatal exposure. Metformin use in pregnancy belongs under obstetric direction only. This is a conversation with a doctor, not a purchase.

Research Highlights

Mechanism Difference
Metformin and berberine are mechanistically redundant. Both partially inhibit mitochondrial Complex I, which raises the AMP to ATP ratio and activates AMPK, which in turn suppresses liver glucose output. Turner 2008 established that pathway for berberine and Foretz 2014 covers it for metformin.The extras differ. Berberine adds PCSK9, PTP1B and NPC1L1 suppression with LDL receptor upregulation, which is why its lipid and liver numbers hold up. Metformin adds intestinal glucose absorption delay and indirect mTOR modulation. Stacking them doubles the shared mechanism and the shared gut side effects.
Safety Comparison
The prescription drug has the better documented safety profile. Metformin's worst case is metformin-associated lactic acidosis, rare but high-mortality, concentrated below eGFR 30 and in hypoxia, sepsis, severe liver disease, alcohol abuse and iodinated contrast procedures. Long-term users need B12 monitoring, per Ballal 2025 and Hussain 2025.Berberine's risks are less visible. Guo 2012 showed repeated dosing inhibits CYP2D6, CYP2C9 and CYP3A4 in humans, which puts statins, warfarin, DOACs, cyclosporine, tacrolimus and macrolides in play. Chan 1993 supports the pregnancy and neonatal contraindications.
Cost Comparison
The prescription is the cheaper option. Generic immediate-release metformin runs $4 to $15 a month through pharmacy discount programs and generic extended-release runs $15 to $30, both priced 2026-09-07 and extracted from the source report rather than estimated.Berberine HCl at the trial dose of 1.5 g a day runs $15 to $25, and dihydroberberine runs $40 to $60. Both sit under $30 for the common protocols, so cost should not decide this one.
Editorial Verdict
Metformin scores 6.9 and berberine 6.8, so the composite tells you nothing. Take metformin when the target is blood sugar in diagnosed disease. Its subrating is 9.0, and UKPDS 34 and DPP are outcome trials rather than marker studies.Take berberine when fatty liver is the target, when you train hard enough that Walton 2019 and Konopka 2019 matter to you, or when no prescriber will write it. Check it against your medication list first, because its CYP interaction surface is wider than its OTC status suggests.
Evidence Quality
These two sit on different evidence tiers. Metformin carries landmark randomized trials with hard endpoints: UKPDS 34 in 753 overweight patients, DPP in 3,234 people at risk, and ten-year post-trial follow-up in Holman 2008.Berberine carries volume rather than depth. Shi 2025 reviewed 54 systematic reviews and found broadly favorable associations at mostly low or very low GRADE quality. Liu 2025 and Nie 2024 are the strongest individual pools, and both aggregate small, mostly regional trials.
No Head To Head Trial
No trial has randomized people to metformin against berberine and reported the result. Every comparison on this page is indirect, built from each side's own placebo-controlled evidence and from the BioHarmony subratings on the two source reports.That matters most on blood sugar, where berberine is often sold as a natural equivalent to metformin. The claim has never been tested head to head at the dose and duration that would settle it, so treat any equivalence claim you read as marketing rather than measurement.

Frequently Asked Questions

Is berberine as good as metformin?: For blood sugar, no. Metformin's subrating is 9.0 against berberine's 8.2, and metformin has outcome trials while berberine has meta-analyses of small marker studies. Berberine does beat it on fatty liver, 7.5 against 5.5, and it does not blunt training adaptation. No trial has ever randomized people to one against the other, so any strict equivalence claim is unsupported.
Can I take metformin and berberine together?: There is no good reason to. Both partially inhibit mitochondrial Complex I and activate AMPK, so the mechanisms are redundant rather than additive. What stacks reliably is the gut burden, since loose stools and cramping are the main side effect of each. If your current one is not working after a full 12 weeks, switch instead of adding.
Which is cheaper, metformin or berberine?: Metformin, usually. Generic immediate-release runs $4 to $15 a month through pharmacy discount programs and extended-release runs $15 to $30. Berberine HCl at the studied 1.5 g a day runs $15 to $25, and dihydroberberine runs $40 to $60. Both figures were extracted from the source reports and priced 2026-09-07.
How long before I know whether it is working?: Twelve weeks on either one. Berberine moves post-meal glucose within about seven days and metformin moves fasting glucose within about a week, but the assessment window on both reports is 12 weeks and full effect lands at 12 weeks. Book the follow-up labs at the start so the decision gets made on numbers.
Does berberine interact with my medications?: Quite possibly. Guo 2012 showed repeated berberine dosing inhibits CYP2D6, CYP2C9 and CYP3A4 in humans, which covers statins, warfarin and DOACs, cyclosporine, tacrolimus, macrolides and many antidepressants.Being sold without a prescription says nothing about interaction risk. Take your full medication list to a pharmacist before the first capsule, especially with transplant drugs or anticoagulants.
Will metformin hurt my gym results?: The signal says it can. Walton 2019 ran a 14-week resistance-training trial in older adults and found metformin blunted the hypertrophy response. Konopka 2019 found attenuated aerobic and mitochondrial adaptation over 12 weeks. If training adaptation is the point of your program, that tradeoff belongs in the decision, and berberine carries no equivalent finding.
Is metformin a longevity drug?: Not yet, on the evidence. Barzilai 2016 makes the case for testing it, and TAME was designed to run that test, but no randomized healthy-adult longevity result has read out. Bannister 2014 is observational and confounded by treatment selection. Its own report calls healthy-adult longevity use speculative.
Who should avoid each one?: Metformin is contraindicated below eGFR 30 and in acute kidney injury, sepsis, severe dehydration, severe liver disease, active alcohol abuse, decompensated heart failure and hypoxic states, and needs a hold around iodinated contrast.Berberine is out in pregnancy, breastfeeding, neonates and jaundiced infants, while trying to conceive without guidance, and alongside warfarin, DOACs, statins, cyclosporine, tacrolimus or CYP-sensitive polypharmacy.

Evidence Sources

RCT UKPDS 34: effect of intensive blood-glucose control with metformin in overweight patients with type 2 diabetes (1998) 753 overweight newly diagnosed patients. Lower diabetes-related endpoints, diabetes-related death, all-cause mortality and myocardial infarction versus conventional policy.
RCT Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (DPP) (2002) n=3,234. Metformin cut diabetes incidence 31% and lifestyle cut it 58% versus placebo.
RCT 10-year follow-up of intensive glucose control in type 2 diabetes (2008) UKPDS post-trial monitoring. The metformin subgroup kept lower diabetes-related endpoints, myocardial infarction and all-cause mortality.
Systematic review Metformin in polycystic ovary syndrome: systematic review and meta-analysis (2003) 13 RCTs in 543 women with PCOS. Metformin improved ovulation odds versus placebo or no treatment.
RCT Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults (2019) 12-week RCT. Metformin attenuated aerobic-fitness and mitochondrial-respiration adaptations in older adults.
RCT MASTERS trial: metformin blunts muscle hypertrophy with resistance training (2019) 14-week multicenter RCT. Metformin blunted the hypertrophy response to progressive resistance training in older adults.
Systematic review Efficacy and safety of berberine on the components of metabolic syndrome (2025) 12 randomized placebo-controlled trials, 889 patients. Lower triglycerides, fasting glucose, waist circumference, LDL-C, total cholesterol, BMI and 2-hour glucose. No effect on HDL-C or blood pressure.
Systematic review Clinical efficacy and safety of berberine in non-alcoholic fatty liver disease (2024) 10 RCTs, 811 NAFLD patients. Improved liver enzymes, lipids, insulin resistance, BMI and steatosis-related markers.
RCT Efficacy of berberine in patients with non-alcoholic fatty liver disease (2015) 184-patient NAFLD trial. 500 mg three times daily for 16 weeks as an adjunct to lifestyle change.
Systematic review Meta-analysis of the effect and safety of berberine in type 2 diabetes, hyperlipemia and hypertension (2015) Supports glucose and lipid improvements across randomized trials of berberine.
Systematic review Berberine and health outcomes: overview of systematic reviews (2025) 54 systematic reviews. Broadly favorable associations at mostly low or very low AMSTAR-2 and GRADE quality.
RCT Repeated administration of berberine inhibits cytochromes P450 in humans (2012) Human dosing study supporting CYP2D6, CYP2C9 and CYP3A4 interaction concerns with berberine.
Observational Displacement of bilirubin from albumin by berberine (1993) Mechanistic basis for the pregnancy, breastfeeding and neonatal jaundice contraindications on berberine.
Mechanistic Berberine and dihydroberberine inhibit mitochondrial respiratory Complex I and activate AMPK (2008) Mechanistic foundation for AMPK activation through mitochondrial Complex I inhibition, the pathway berberine shares with metformin.
Review Metformin: from mechanisms of action to therapies (2014) Mechanism review covering AMPK, hepatic gluconeogenesis, mitochondrial Complex I, gut effects and therapeutic translation.
RCT Berberine-containing triple therapy for initial H. pylori treatment (2023) 300 H. pylori-infected patients. The berberine-containing regimen was comparable to vonoprazan and rabeprazole quadruple therapy arms.
Systematic review Efficacy and safety of berberine plus 5-ASA for ulcerative colitis (2024) 10 RCTs, 952 ulcerative colitis patients. Berberine added to 5-ASA improved clinical efficacy and inflammatory or endoscopic markers.
Systematic review Effect of berberine on obesity indices: systematic review and meta-analysis (2026) 23 trials. Modest reductions in body weight, BMI and waist circumference, with no significant waist-hip ratio effect.
Label FDA metformin kidney-function labeling update and iodinated contrast precautions (2017) eGFR thresholds. Contraindicated below 30, do not start between 30 and 45, and hold around iodinated contrast in specific risk contexts.
Regulatory EFSA 2026 draft opinion consultation on plant preparations containing berberine (2026) Open European safety review of berberine-containing plant preparations. Availability in the EU could change on the outcome.

Glossary

Quick reference for the medical and technical terms used in this comparison.

AMPK AMP-Activated Protein Kinase: The cell's low-fuel sensor. Switching it on tells the liver to stop making glucose. Both metformin and berberine activate it, which is why they are mechanistically redundant.
Complex I Mitochondrial Respiratory Complex I: The first station in the mitochondrial energy chain. Both drugs partially inhibit it, which raises the AMP to ATP ratio and turns on AMPK.
HbA1c Glycated Hemoglobin: A rolling 2 to 3 month average of blood glucose. The endpoint that decides whether either of these is working, read at about 12 weeks.
PCOS Polycystic Ovary Syndrome: A hormonal condition often driven by insulin resistance. Both interventions are used for it, and metformin has the pooled ovulation evidence in Lord 2003.
MALA Metformin-Associated Lactic Acidosis: Metformin's worst-case risk. Rare, but high-mortality, and concentrated in kidney impairment, hypoxia, sepsis, severe liver disease and alcohol abuse.
eGFR Estimated Glomerular Filtration Rate: A kidney-function number. Metformin is contraindicated below 30 and should not be started between 30 and 45, per the FDA labeling update.
NAFLD Non-Alcoholic Fatty Liver Disease: Fat accumulation in the liver without alcohol as the cause. Berberine's strongest row, with Nie 2024 and Yan 2015 behind it.
CYP Cytochrome P450 Enzymes: The liver enzymes that clear most drugs. Berberine inhibits CYP2D6, CYP2C9 and CYP3A4, which is where its interaction risk comes from.
PCSK9 Proprotein Convertase Subtilisin/Kexin type 9: A protein that degrades LDL receptors. Berberine suppresses it, which is part of why its lipid numbers move and metformin's do not.

Nick Urban Health Optimization Researcher & CHEK Holistic Lifestyle Coach Level 2

I've spent over a decade testing metabolic interventions on myself and screening them for clients and podcast guests

Reviewed Sep 7, 2026 · next review Dec 6, 2026

Find which one fits your biology

Take the BioHarmony Quiz